Added to YB: 2019-08-05
Pitch date: 2019-08-05
NVCR:US [bullish]
NovoCure Limited
-83.77%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally.
Market Cap
$1.3B
Pitch Price
$82.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.91
P/E
-7.04
EV/Sales
1.61
Sector
Health Care Equipment and Supplies
Category
N/A
Show full summary:
NOVOCURE LTD COM NVCR:US
A summary for this pitch has not been created yet.
Read full article (0 min)